DYAI
DYADIC INTERNATIONAL INC
Key Financials
Revenue
$3.1M
↓ 11.6%
Operating Income
$-7192816
↓ 21.9%
Net Income
$-7364628
↓ 26.8%
Total Liabilities
$8.7M
↑ 16.8%
EPS (Diluted)
$-0.23
↓ 15.0%
Shareholders' Equity
$1.2M
↓ 50.1%
Total Assets
$9.9M
↑ 0.2%
Cash & Equivalents
$4.6M
↓ 29.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 6/22/2026 | View on SEC |
| DEFA14A | 6/18/2026 | View on SEC |
| 8-K | 6/18/2026 | View on SEC |
| 8-K | 6/15/2026 | View on SEC |
| 8-K | 5/28/2026 | View on SEC |
| 8-K | 5/13/2026 | View on SEC |
| 10-Q | 5/13/2026 | View on SEC |
| DEF 14A | 5/12/2026 | View on SEC |
| SCHEDULE 13G/A | 5/11/2026 | View on SEC |
| SCHEDULE 13G | 5/11/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | DYAI |
| Company Name | DYADIC INTERNATIONAL INC |
| CIK | 1213809 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 561-743-8333 |